<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">A vastly smaller number of patients with EVD received treatment outside of Africa, including 11 in the United States and 16 in Europe.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> Of these 27 patients, the majority were infected in West Africa, but 2 patients were nurses who were secondarily infected following exposure to a man with EVD who had traveled recently to Liberia. These cases of imported EVD increased awareness of the risk of viral hemorrhagic fevers in a globalized world, but, more practically, it also demonstrated to clinicians in industrialized countries the intensity of resources, staffing, and training required to safely care for patients with EVD. The mortality of patients with EVD treated in industrialized countries was low compared with the experience in West Africa (5/27 total patients, or 18.5%),
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> with the successful implementation of critical care interventions previously thought to be futile, including mechanical ventilation and renal replacement therapy. At the same time, the low numbers of cases permitted an intensity of care in the United States and Europe that may not be feasible in a generalized outbreak.
</p>
